Concepedia

Author

Minehiko Inomata

Toyama University HospitalORCID

Also Known As

M Inomata, M. Inomata, MINEHIKO INOMATA, Minehiko Inomata

97

Publications

674

Citations

15

H-Index

24

Concepts

All Affiliations

Toyama University HospitalUniversity of ToyamaToyama Prefectural Central HospitalKushiro City General HospitalOita University
MI

About

Minehiko Inomata is an author at Toyama University Hospital specializing in medicine, oncology, and lung cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

82

2

Health Sciences

3

3

47

3

Pathology

2

2

37

4

Pharmacology

1

1

20

5

Pulmonary Disease

1

1

15

Minehiko Inomata

×

23

Publications

536

Citations

15

H-Index

YearCitations

Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin‐induced mouse model of asthma

Tomomi Ichikawa, Ryuji Hayashi, Kensuke Suzuki,

Respirology

2012

88

Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study

Kensuke Suzuki, Hideaki Furuse, Takeshi Tsuda,

Journal of International Medical Research

2015

52

Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor

Minehiko Inomata, Tomonobu Kado, Seisuke Okazawa,

Anticancer Research

2019

46

Continuous administration of EGFR-TKIs following radiotherapy after disease progression in bone lesions for non-small cell lung cancer.

Minehiko Inomata, Takehito Shukuya, Toshiaki Takahashi,

PubMed

2011

26

Prognostic Significance of the p53 Mutation in Esophageal Cancer

S. Uchino, Toshiaki Saito, Minehiko Inomata,

Japanese Journal of Clinical Oncology

1996

25

SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients

Chihiro Taka, Ryuji Hayashi, Kazuki Shimokawa,

International Journal of COPD

2017

23

Miliary brain metastasis presenting with calcification in a patient with lung cancer: a case report

Minehiko Inomata, Ryuji Hayashi, Kenta Kambara,

Journal of Medical Case Reports

2012

22

Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib

Minehiko Inomata, Ryuji Hayashi, Hiroaki Tanaka,

Molecular and Clinical Oncology

2016

22

Visceral adipose tissue level, as estimated by the bioimpedance analysis method, is associated with impaired lung function

Minehiko Inomata, Yukio Kawagishi, Chihiro Taka,

Journal of Diabetes Investigation

2011

21

Lactate Dehydrogenase and Body Mass Index are Prognostic Factors in Patients with Recurrent Small Cell Lung Cancer Receiving Amrubicin

Minehiko Inomata, Ryuji Hayashi, Kotaro Tokui,

Tumori Journal

2015

21

Page 1